Clinical Trial: Phase 1 Clinical Study of MWN105 Injection in Participants With Overweight or Obesity

U.S., Sept. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07803809) titled 'Phase 1 Clinical Study of MWN105 Injection in Participants With Overweight or Obesity' on Sept. 01.

Brief Summary: This study is a randomized, double-blind, placebo-controlled, multiple-dose, dose-escalation phase I clinical trial aiming to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and immunogenicity of MWN105 injection in Chinese non-diabetic overweight or obese participants.

The study plans to enroll 36 male and female participants. Three dose groups were preset, with 12 participants in each. They were randomly assigned to receive MWN105 injection or placebo at a ratio of 5:1 and were administered the...